|Articles|June 29, 2023

DIA 2023: Impact of Exclusionary Behaviors on Team Dynamics

In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Emily Botto, research analyst, Tufts CSDD discusses a recent study on the impact of exclusionary behaviors on team dynamics conducted by Tufts. An article on the study was previously featured on ACT, which can be found here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

2026 DIA Global Annual Meeting: Why Federated Learning Reduces Friction

June 26th 2026

Sponsored Content

Applied Clinical Trials at the 2026 DIA Global Annual Meeting: Conversations on Data, Outsourcing, and the Patient Voice

ByAndy Studna, Senior Editor

June 26th 2026

Jonathan Andrus, CRIO, on Why Site-Sponsor Data Fragmentation Persists and What Central eSource Can Do About It

ByJonathan Andrus,Andy Studna, Senior Editor

June 25th 2026

2026 DIA Global Annual Meeting: On Leadership, Obesity, and the Science That's Redefining What's Possible

ByMarwan Fathallah,Andy Studna, Senior Editor

June 24th 2026

2026 DIA Global Annual Meeting: Where Mixed Models Create the Most Value—and What It Takes to Make Them Work

BySamantha Hadfield,Nick Scott,Andy Studna, Senior Editor

June 22nd 2026

Trending on Applied Clinical Trials Online

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

One Clinical: Working Together to Advance Trial Collaboration

FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices